查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1611537

Fill Finish 藥品契約製造市場規模、佔有率、趨勢分析報告：按產品、按分子、按最終用途、按地區、細分市場預測，2025-2030 年

Fill-finish Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Prefilled Syringes, Vials, Cartridges), By Molecule (Large, Small), By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

Fill Finish 藥品契約製造市場的成長和趨勢

根據 Grand View Research, Inc. 的最新報告，預計 2025 年至 2030 年全球灌裝藥品契約製造市場將以 8.3% 的複合年成長率成長，到 2030 年將達到 290.6 億美元。

對注射藥物的需求不斷成長是 Fillfinish 藥品契約製造市場的關鍵促進因素之一。注射藥物是使用針頭和注射器或其他輸送系統直接輸送到血液、肌肉組織或身體其他部位的藥物。這些藥物用於治療多種疾病，包括癌症、自體免疫疾病和感染疾病。

近年來，由於多種因素，注射藥物的需求穩定成長。關鍵促進因素之一是癌症和糖尿病等需要長期注射藥物治療的慢性疾病的盛行率不斷上升。此外，通常透過注射給藥的新生技藥品的開發也有助於增加對注射藥物的需求。

COVID-19大流行對市場產生了重大影響。灌裝加工契約製造是製藥業的重要業務，將藥品填充到管瓶、注射器、藥筒和其他輸送系統中。疫情擾亂了全球供應鏈，導致原料和營運所需的其他關鍵零件短缺。這導致藥物和疫苗的生產延遲，特別是用於治療 COVID-19 患者的藥物和疫苗。

此外，疫情也導致某些藥品和疫苗的需求增加，進一步導致成品契約製造製造商的產能緊張。由於社交距離準則和為遏制病毒傳播而實施的其他限制，許多製造商被迫減少產能。

Fill Finish 藥品契約製造市場報告亮點

  • 由於解決未滿足的醫療需求的可能性越來越大，大分子將在 2024 年佔據最大的銷售佔有率，達到 67.3%。
  • 由於管瓶灌裝設備技術不斷進步，2024年管瓶產業將佔據最高的銷售佔有率，達到53.4%。
  • 生物製藥公司細分市場在2024年的收益佔有率最高，為55.3%，藥物和疫苗的持續開發是市場成長的主要驅動力。
  • 按地區分類，北美的灌裝醫藥契約製造市場在全球市場佔據主導地位，2024年銷售佔有率為34.9%。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章 Fill Finish 藥品契約製造市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 營商環境分析
    • 產業分析-波特五力分析
    • PESTLE分析

第 4 章 Fill Finish 藥品契約製造市場：產品業務分析

  • 2024年及2030年產品市場佔有率
  • 產品細分儀表板
  • 2018-2030 年按產品分類的市場規模、預測與趨勢分析
  • 預填充式注射器
  • 管瓶
  • 墨水匣
  • 其他

第5章 Fill Finish 藥品契約製造市場：分子業務分析

  • 2024年及2030年分子市場佔有率
  • 分子細分儀表板
  • 2018-2030 年按分子分類的市場規模、預測與趨勢分析
  • 高分子
  • 小分子

第6章 Fill Finish 藥品契約製造市場：最終用途業務分析

  • 2024 年及 2030 年最終用途市場佔有率
  • 最終用途細分儀表板
  • 2018-2030 年按最終用途分類的市場規模、預測與趨勢分析
  • 生物製藥公司
  • 製藥公司

第 7 章 Fill Finish 藥品契約製造市場：按產品、分子和最終用途按地區進行估計和趨勢分析

  • 2024 年及 2030 年按地區分類的市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 按國家/地區分類，2018-2030
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 按國家/地區分類，2018-2030
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 按國家/地區分類，2018-2030
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 按國家/地區分類，2018-2030
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 按國家/地區分類，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 參與者概覽
  • 公司市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介/上市公司
    • Thermo Fisher Scientific Inc.
    • Sartorius AG
    • Boehringer Ingelheim International GmbH
    • Catalent, Inc（acquired by Novo Holdings A/S）
    • Societal CDMO（Recro Pharma, Inc）
    • Baxter
    • Eurofins Scientific
    • Symbiosis Pharmaceutical Services Ltd
    • MabPlex International Co. Ltd.
    • Recipharm AB
    • Fresenius Kabi, USA LLC
    • Lonza
Product Code: GVR-4-68039-949-4

Fill-Finish Pharmaceutical Contract Manufacturing Market Growth & Trends:

The global fill-finish pharmaceutical contract manufacturing market size is estimated to reach USD 29.06 billion by 2030, expanding at a CAGR of 8.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for injectable drugs is one of the primary drivers of the fill-finish pharmaceutical contract manufacturing market. Injectable drugs are medications that are delivered directly into the bloodstream, muscle tissue, or other parts of the body using a needle and syringe or other delivery system. These drugs are used to treat a wide range of conditions, including cancer, autoimmune disorders, and infectious diseases, among others.

The demand for injectable drugs has been growing steadily in recent years due to several factors. One of the key drivers is the increasing prevalence of chronic diseases such as cancer and diabetes, which require long-term treatment with injectable medications. Additionally, the development of new biologic drugs, which are often administered via injection, has also contributed to the growing demand for injectable drugs.

The COVID-19 pandemic has had a significant impact on the market. Fill-finish contract manufacturing is an essential part of the pharmaceutical industry, which involves the filling and finishing of drug products into vials, syringes, cartridges, and other delivery systems. The pandemic caused disruptions in the global supply chain, resulting in shortages of raw materials and other critical components required for operations. This has led to delays in the production of drugs and vaccines, particularly those used in the treatment of COVID-19 patients.

Moreover, the pandemic has also caused an increase in demand for certain drugs and vaccines, further straining the capacity of fill-finish contract manufacturers. Many manufacturers have been forced to operate at reduced capacity due to social distancing guidelines and other restrictions imposed to control the spread of the virus.

Fill-Finish pharmaceutical Contract Manufacturing Market Report Highlights:

  • The large molecules segment accounted for the largest revenue share of 67.3% in 2024 due to the rising potential to treat unmet medical needs.
  • The vials segment is accounted for the highest revenue share of 53.4% in 2024 due to increasing technological advancements in vial filling equipment.
  • The biopharmaceutical companies segment accounted for the highest revenue share of 55.3% in 2024, an increase in the development of drugs and vaccines is the key factor for the growth of the market.
  • By region, North America fill-finish pharmaceutical contract manufacturing market dominated the global market with a revenue share of 34.9% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Molecule
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Fill-finish Pharmaceutical Contract Manufacturing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Fill-finish Pharmaceutical Contract Manufacturing Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Prefilled Syringes
    • 4.4.1. Prefilled Syringes Market, 2018 - 2030 (USD Million)
  • 4.5. Vials
    • 4.5.1. Vials Market, 2018 - 2030 (USD Million)
  • 4.6. Cartridges
    • 4.6.1. Cartridges Market, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Fill-finish Pharmaceutical Contract Manufacturing Market: Molecule Business Analysis

  • 5.1. Molecule Market Share, 2024 & 2030
  • 5.2. Molecule Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Molecule, 2018 to 2030 (USD Million)
  • 5.4. Large Molecules
    • 5.4.1. Large Molecules Market, 2018 - 2030 (USD Million)
  • 5.5. Small Molecules
    • 5.5.1. Small Molecules Market, 2018 - 2030 (USD Million)

Chapter 6. Fill-finish Pharmaceutical Contract Manufacturing Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Biopharmaceutical Companies
    • 6.4.1. Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 6.5. Pharmaceutical Companies
    • 6.5.1. Pharmaceutical Companies Market, 2018 - 2030 (USD Million)

Chapter 7. Fill-finish Pharmaceutical Contract Manufacturing Market: Regional Estimates & Trend Analysis by Product, Molecule, and End Use

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Thermo Fisher Scientific Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Sartorius AG
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Boehringer Ingelheim International GmbH
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Catalent, Inc (acquired by Novo Holdings A/S)
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Societal CDMO (Recro Pharma, Inc)
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Baxter
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Eurofins Scientific
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Symbiosis Pharmaceutical Services Ltd
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. MabPlex International Co. Ltd.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Recipharm AB
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. Fresenius Kabi, USA LLC
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial Performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives
    • 8.5.12. Lonza
      • 8.5.12.1. Overview
      • 8.5.12.2. Financial Performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global fill-finish pharmaceutical contract manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 5 Global fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 6 Global fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America fill-finish pharmaceutical contract manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 10 North America fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 11 U.S. fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 12 U.S. fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 13 U.S. Fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Canada fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 15 Canada fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 16 Canada fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Mexico fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 18 Mexico fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 19 Mexico fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Europe fill-finish pharmaceutical contract manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 23 Europe fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 24 UK fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 25 UK fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 26 UK Fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Germany fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 28 Germany fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 29 Germany fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 30 France fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 31 France fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 32 France Fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Italy fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 34 Italy fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 35 Italy fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Spain fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 37 Spain fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 38 Spain fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Norway fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 40 Norway fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 41 Norway Fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 42 Denmark fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 43 Denmark fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 44 Denmark fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Sweden fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 46 Sweden fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 47 Sweden fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific fill-finish pharmaceutical contract manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Japan fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 53 Japan fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 54 Japan fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 55 China fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 56 China fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 57 China fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 58 India fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 59 India fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 60 India fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Australia fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 62 Australia fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 63 Australia fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 64 South Korea fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 65 South Korea fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 66 South Korea fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 67 Thailand fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 68 Thailand fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 69 Thailand fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Latin America fill-finish pharmaceutical contract manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 71 Latin America fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 72 Latin America fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 73 Latin America fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 74 Brazil fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 75 Brazil fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 76 Brazil fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 77 Argentina fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 78 Argentina fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 79 Argentina fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Fill-finish pharmaceutical contract manufacturing market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 84 South Africa fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 85 South Africa fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 86 South Africa fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 90 UAE fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 91 UAE fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 92 UAE fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait fill-finish pharmaceutical contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 94 Kuwait fill-finish pharmaceutical contract manufacturing market, by molecule, 2018 - 2030 (USD Million)
  • Table 95 Kuwait fill-finish pharmaceutical contract manufacturing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Fill-finish pharmaceutical contract manufacturing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Product and molecule outlook (USD Million)
  • Fig. 10 End use outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Fill-finish pharmaceutical contract manufacturing market dynamics
  • Fig. 13 Fill-finish pharmaceutical contract manufacturing market: Porter's five forces analysis
  • Fig. 14 Fill-finish pharmaceutical contract manufacturing market: PESTLE analysis
  • Fig. 15 Fill-finish pharmaceutical contract manufacturing market: Product segment dashboard
  • Fig. 16 Fill-finish pharmaceutical contract manufacturing market: Product market share analysis, 2024 & 2030
  • Fig. 17 Prefilled syringes market, 2018 - 2030 (USD Million)
  • Fig. 18 Vials market, 2018 - 2030 (USD Million)
  • Fig. 19 Cartridges market, 2018 - 2030 (USD Million)
  • Fig. 20 Others market, 2018 - 2030 (USD Million)
  • Fig. 21 Fill-finish pharmaceutical contract manufacturing market: Molecule segment dashboard
  • Fig. 22 Fill-finish pharmaceutical contract manufacturing market: Molecule market share analysis, 2024 & 2030
  • Fig. 23 Large molecules market, 2018 - 2030 (USD Million)
  • Fig. 24 Small molecules market, 2018 - 2030 (USD Million)
  • Fig. 25 Fill-finish pharmaceutical contract manufacturing market: End use segment dashboard
  • Fig. 26 Fill-finish pharmaceutical contract manufacturing market: End use market share analysis, 2024 & 2030
  • Fig. 27 Biopharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 28 Pharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 29 Fill-finish pharmaceutical contract manufacturing market revenue, by region
  • Fig. 30 Regional marketplace: Key takeaways
  • Fig. 31 Regional marketplace: Key takeaways
  • Fig. 32 North America fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. country dynamics
  • Fig. 34 U.S. fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 35 Canada country dynamics
  • Fig. 36 Canada fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico country dynamics
  • Fig. 38 Mexico fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 40 UK country dynamics
  • Fig. 41 UK fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 42 Germany country dynamics
  • Fig. 43 Germany fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 44 France country dynamics
  • Fig. 45 France fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 46 Italy country dynamics
  • Fig. 47 Italy fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 48 Spain country dynamics
  • Fig. 49 Spain fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 50 Norway country dynamics
  • Fig. 51 Norway fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden country dynamics
  • Fig. 53 Sweden fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark country dynamics
  • Fig. 55 Denmark fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 57 Japan country dynamics
  • Fig. 58 Japan fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 59 China country dynamics
  • Fig. 60 China fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 61 India country dynamics
  • Fig. 62 India fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 63 Australia country dynamics
  • Fig. 64 Australia fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 65 South Korea country dynamics
  • Fig. 66 South Korea fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 67 Thailand country dynamics
  • Fig. 68 Thailand fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 69 Latin America fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 70 Brazil country dynamics
  • Fig. 71 Brazil fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 72 Argentina country dynamics
  • Fig. 73 Argentina fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 74 MEA fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 75 South Africa country dynamics
  • Fig. 76 South Africa fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 77 Saudi Arabia country dynamics
  • Fig. 78 Saudi Arabia fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 79 UAE country dynamics
  • Fig. 80 UAE fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 81 Kuwait country dynamics
  • Fig. 82 Kuwait fill-finish pharmaceutical contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 83 Company categorization
  • Fig. 84 Company market position analysis
  • Fig. 85 Strategic framework